Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -4.734\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) CCOC(=O)c1c(C)nc2c(c1-c1ccc(OC)c(OC)c1)C(=O)c1ccccc1-2
b) CC(C)CCN1CCN(C/C=C/c2ccco2)CC1CCO
c) CN1CCN(c2ccc([N+](=O)[O-])c(N/N=C3\CN4CCC3CC4)c2)CC1
d) COc1ccc(-c2csc(NC(=O)CSc3nnnn3C)n2)c(OC)c1
e) Cc1ccc(CC2CC(=O)N(c3nc(C)cc(C)n3)C2=O)cc1
Answer: a. CCOC(=O)c1c(C)nc2c(c1-c1ccc(OC)c(OC)c1)C(=O)c1ccccc1-2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)c1c(C)nc2c(c1-c1ccc(OC)c(OC)c1)C(=O)c1ccccc1-2
CCOC(=O)c1c(C)nc2c(c1-c1ccc(OC)c(OC)c1)C(=O)c1ccccc1-2
ethyl 4-(3,4-dimethoxyphenyl)-2-methyl-5-oxoindeno[1,2-b]pyridine-3-carboxylate